Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus

被引:26
作者
Ram Ayyar D. [1 ]
Sharma K.R. [1 ]
机构
[1] Department of Neurology, Univ. of Miami School of Medicine, Miami, FL 33136
关键词
Neuropathy; Amyotrophic Lateral Sclerosis; Diabetic Neuropathy; Compound Muscle Action Potential; Chronic Inflammatory Demyelinating Polyneuropathy;
D O I
10.1007/s11892-004-0048-y
中图分类号
学科分类号
摘要
There is a higher incidence of demyelinating peripheral neuropathy responsive to immunomodulating treatment in patients with diabetes mellitus. The diagnosis is often overlooked and the patients are given the label of "diabetic neuropathy." Progressive symmetric or asymmetric motor deficit, progressive sensory neuropathy in spite of optimal diabetic control, and unusually high cerebrospinal fluid protein level in "diabetic neuropathy" should alert the clinician to the possibility of an underlying treatable demyelinating peripheral neuropathy masquerading as "diabetic neuropathy." Copyright © 2004 by Current Science Inc.
引用
收藏
页码:409 / 412
页数:3
相关论文
共 36 条
  • [1] Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP), Neurology, 41, pp. 617-618, (1991)
  • [2] Rotta F.T., Sussman A.T., Bradley W.G., Et al., The spectrum of chronic inflammatory demyelinating polyneuropathy, J. Neurol. Sci., 173, pp. 129-139, (2000)
  • [3] Van Doorn P.A., Rossi F., Brand A., Et al., On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy, J. Neuroimmunol., 29, pp. 57-64, (1990)
  • [4] Frank M.M., Basta M., Fries L.F., The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues, Clin. Immunol. Immunopathol., 62, 1 PART 2, (1992)
  • [5] Dalakas M.C., Mechanisms of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases, Neurology, 51, SUPPL., (1998)
  • [6] Griffin J.W., George R., Lobato C., Et al., Macrophage responses and myelin clearance during Wallerian degeneration: Relevance to immune-mediated demyelination, J. Neuroimmunol., 40, pp. 153-165, (1992)
  • [7] Miyagi F., Horiuchi H., Nagata I., Et al., Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis, J. Neuroimmunol., 78, pp. 127-131, (1997)
  • [8] Saoudi A., Hurez V., de Kozak Y., Et al., Human immunogloblin preparations for intravenous use (IVIg) prevent experimental autoimmune uveoretinitis, Int. Immunol., 5, pp. 1559-1567, (1993)
  • [9] Anderson C.L., Human IgG Fc receptors, Clin. Immunol. Immunopathol., 53, 2 PART 2, (1989)
  • [10] Boulton A.J.M., Angus E., Ayyar D.R., Et al., Diabetic thoracic polyradiculopathy presenting as an abdominal swelling, BMJ, 289, pp. 798-799, (1984)